Skip to content

Clinical trials

Phase 1 Stomach Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Country / region: Netherlands Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20132
20151
20161
20171
20181
20202
20223
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Amgen2
Novartis Pharmaceuticals2
Seagen, a wholly owned subsidiary of Pfizer2
BioNTech Cell & Gene Therapies GmbH1
Bristol-Myers Squibb1
Eli Lilly and Company1
Erasmus Medical Center1
Exelixis1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms19
Colorectal Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Breast Neoplasms5
Esophageal Neoplasms5
Lung Neoplasms5
Ovarian Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Carcinoma, Renal Cell4
Neoplasms4

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.